within Pharmacolibrary.Drugs.D_Dermatologicals.D10A_AntiAcnePreparationsForTopicalUse.D10AF01_Clindamycin;
model Clindamycin 
   extends Pharmacolibrary.Drugs.ATC.D.D10AF01;

  annotation(Documentation(
    info ="<html><body><p>Clindamycin is a lincosamide antibiotic used to treat a variety of bacterial infections, including skin, soft tissue, respiratory tract, bone, and joint infections. It is approved and widely used today for susceptible Gram-positive infections and some anaerobic pathogens.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><p>Bassetti, M, et al., &amp; Giacobbe, DR (2022). Current pharmacotherapy for methicillin-resistant . <i>Expert opinion on pharmacotherapy</i> 23(3) 361–375. DOI:<a href=&quot;https://doi.org/10.1080/14656566.2021.2010706&quot;>10.1080/14656566.2021.2010706</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34882041/&quot;>https://pubmed.ncbi.nlm.nih.gov/34882041</a></p></li><li><p>Batzias, GC, et al., &amp; Athanasiou, LV (2005). Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs. <i>Veterinary journal (London, England : 1997)</i> 170(3) 339–345. DOI:<a href=&quot;https://doi.org/10.1016/j.tvjl.2004.06.007&quot;>10.1016/j.tvjl.2004.06.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16266847/&quot;>https://pubmed.ncbi.nlm.nih.gov/16266847</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Clindamycin;
